Perigon Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$920K Buy
37,795
+4,471
+13% +$109K 0.02% 493
2025
Q1
$692K Sell
33,324
-4,712
-12% -$97.8K 0.02% 536
2024
Q4
$922K Sell
38,036
-8,305
-18% -$201K 0.02% 464
2024
Q3
$1.19M Sell
46,341
-3,903
-8% -$99.9K 0.03% 387
2024
Q2
$1.18M Buy
50,244
+13,716
+38% +$322K 0.03% 336
2024
Q1
$1.05M Buy
36,528
+6,945
+23% +$200K 0.03% 359
2023
Q4
$971K Buy
29,583
+3,380
+13% +$111K 0.03% 344
2023
Q3
$730K Buy
26,203
+6,864
+35% +$191K 0.03% 367
2023
Q2
$659K Buy
19,339
+3,803
+24% +$130K 0.03% 390
2023
Q1
$467K Buy
15,536
+1,608
+12% +$48.4K 0.03% 409
2022
Q4
$393K Sell
13,928
-2,806
-17% -$79.2K 0.02% 448
2022
Q3
$550K Sell
16,734
-210
-1% -$6.9K 0.05% 313
2022
Q2
$534K Buy
16,944
+5,736
+51% +$181K 0.04% 319
2022
Q1
$515K Sell
11,208
-249
-2% -$11.4K 0.04% 352
2021
Q4
$702K Sell
11,457
-1,001
-8% -$61.3K 0.05% 273
2021
Q3
$931K Buy
12,458
+779
+7% +$58.2K 0.08% 211
2021
Q2
$1.08M Buy
11,679
+972
+9% +$89.9K 0.1% 184
2021
Q1
$950K Sell
10,707
-73
-0.7% -$6.48K 0.1% 188
2020
Q4
$1.01M Buy
10,780
+2,404
+29% +$224K 0.12% 144
2020
Q3
$534K Buy
8,376
+811
+11% +$51.7K 0.07% 209
2020
Q2
$395K Buy
7,565
+981
+15% +$51.2K 0.06% 221
2020
Q1
$219K Buy
+6,584
New +$219K 0.04% 286
2018
Q2
Sell
-2,770
Closed -$71K 256
2018
Q1
$71K Hold
2,770
0.03% 274
2017
Q4
$68K Buy
+2,770
New +$68K 0.03% 252